In LATAM venture capital arrives too late

By Jonathan Joel Mentor | @jonathanjmentor 

A founder applies to an early-stage program with an unfinished product, a plausible market and a problem worth solving.

The application asks for revenue, customers, retention, acquisition costs, audited performance and evidence that the business model already works.

The founder is told to return when there is more traction.

By then, the company may have survived through personal savings, consulting income, family support or capital raised elsewhere. It may also have disappeared.

This is one of the quiet contradictions inside early-stage finance across Latin America and the Caribbean.

Institutions say they want to support companies before they are proven. Their selection criteria then reward the companies that have already proved themselves without that support.

The problem is not simply that too little capital reaches pre-seed companies.

It is that some of the capital described as pre-seed arrives after the work of discovery has already been completed.

The proof-before-discovery trap

Pre-seed capital has a specific economic purpose.

It finances the period when a company is still determining whether a problem is urgent, which customer will pay, what product is viable, which channel can reach the market and whether the founding team can convert learning into execution.

At this stage, uncertainty is not an administrative inconvenience.

It is the object being financed.

A serious early-stage investor is not expected to eliminate risk before making a decision. The investor must decide which risks are worth testing, what evidence the capital should produce and what will happen once that evidence becomes available.

The contradiction begins when an institution asks founders to provide the very proof that the investment is supposed to help create.

This is the proof-before-discovery trap.

It produces a system in which companies become eligible for early-stage capital only after they have privately financed much of the early stage themselves.

The institution may still select capable businesses. But it is no longer discovering them at pre-seed. It is rewarding the survivors.

What the system is actually selecting

The companies that pass these filters are often the most institutionally legible.

Their founders may have stronger networks, international experience, polished materials, recognizable credentials or enough financial stability to develop the product before seeking outside support.

None of those characteristics disqualifies a company. Many such founders will build excellent businesses.

But legibility and potential are not the same thing.

A founder with an important technical insight, unusual access to an underserved market or deep knowledge of a difficult industry may appear weaker because the evidence remains incomplete.

The company may not yet have revenue because the product requires access to a regulated environment. It may lack customers because the first credible buyer is a corporation or public institution with a long procurement process. It may not have reliable market data because the market itself is poorly documented.

When mature-company evidence is applied to an immature company, two errors become likely.

The first is a false negative: a potentially valuable business is rejected because the institution cannot price what remains unknown.

The second is a false positive: a company is selected because it looks prepared, even though its most important assumptions have never been properly tested.

One error sends potential value elsewhere.

The other finances the appearance of progress.

A check is not a validation system

Many programs treat the early-stage gap as though the only missing element were money.

A check is important. But capital without access may purchase little more than time.

A financial-technology company may need a controlled environment in which to test a product. A logistics startup may need access to a real distribution operation. A tourism company may require a hotel, airport or destination operator willing to become an early customer.

A company selling to government may need a bounded procurement route that allows a pilot to become a contract if the evidence is positive.

The founder cannot manufacture all of those conditions independently.

The institution financing discovery must therefore decide what it is prepared to contribute beyond capital.

That contribution may be data, a paid pilot, a regulated testing environment, an operating partner, a procurement pathway or reserved follow-on funding.

Without it, the founder completes the program with better materials but little more commercial evidence.

The uncertainty has not been resolved.

It has merely been postponed.

The missing decision architecture

A credible pre-seed instrument should make a few decisions visible before the first payment is made.

What consequential uncertainty is being financed?

What is the smallest serious experiment capable of producing credible evidence?

Who will provide the customer, data, operating environment or regulatory access required to conduct it?

What result will trigger additional capital, redesign or closure?

And who has the authority to make that decision?

The sequence is straightforward:

Uncertainty → funded experiment → market evidence → follow-on, redesign or stop

Most entrepreneurship programs already possess applications, mentors, selection committees and demo days.

What they often lack is a pre-agreed path connecting the first check to the second decision.

That distinction matters.

A cohort can be administered without anyone owning the investment logic. A founder can receive advice without the institution deciding what evidence it requires. A pilot can be completed without a buyer, budget or route to scale.

Activity continues.

The company remains unresolved.

Failure should still improve the institution

Not every early-stage experiment should continue.

The purpose of pre-seed capital is not to protect every company from failure. It is to make failure bounded, informative and connected to a decision.

Yet many programs celebrate their winners and quietly forget the ventures that do not survive.

The founder leaves. The cohort closes. A new call for applications is announced.

The institution often retains little knowledge about why the company failed, which customer refused to buy, which technical assumption proved false or which regulatory obstacle prevented adoption.

The next cycle then begins with nearly the same selection logic.

In a market where early-stage capital is scarce, this is an expensive habit.

A failed company may not return cash. But the experiment should still improve institutional judgment.

It should reveal which assumptions matter, which milestones predict commercial progress and which kinds of support create evidence rather than activity.

The relevant question is therefore not only how many startups remain alive.

It is how much useful evidence each investment produced, how quickly the next decision was made and whether the institution became better at allocating its next peso.

Otherwise, the program is not developing investment capability.

It is repeatedly purchasing the same lesson.

Someone must own the next decision

The pre-seed gap is usually described as a founder-readiness problem.

Founders are told to become more disciplined, more presentable, more financially sophisticated and more capable of attracting investors.

That advice is often valid.

But founder preparation cannot repair an instrument whose decision process was never designed for uncertainty.

A fund manager, bank, corporation, public agency or development institution may each approach early-stage finance differently. Their legal responsibilities, risk tolerances and economic objectives are not identical.

Still, any institution claiming to finance pre-seed should be able to answer the same questions:

What uncertainty are we purchasing the right to understand?

Who gives the company access to validation?

Who decides whether the evidence is sufficient?

Is additional capital available if the experiment succeeds?

What happens if the answer is ambiguous?

What does the institution learn if the company closes?

A program manager can administer a cohort.

A mentor can support a founder.

Neither substitutes for an investment owner capable of deciding what the portfolio is meant to discover.

A standard appropriate to the stage

Latin America and the Caribbean do not need indiscriminate investment or fashionable losses.

They need standards appropriate to the stage being financed.

For an established company, investability may mean stable revenue, predictable operations and documented capacity to grow or repay capital.

For a pre-seed company, investability means something different:

A consequential uncertainty.
A credible team.
A testable hypothesis.
Access to the environment required to learn.
A financing structure that converts evidence into a decision.

That is not a weaker standard.

It is a more honest one.

An institution may reasonably decide that it only wants companies with traction, revenue and validated demand. It may be offering seed capital, growth financing, procurement or a small-business facility.

Those are legitimate instruments.

But capital that requires the company to complete discovery before it becomes eligible is not financing pre-seed.

It is arriving after pre-seed is over.

The region may already possess more promising companies than its investment pipelines suggest.

What remains missing is not always potential.

Sometimes it is an institutional process capable of recognizing potential before someone else has already financed the proof.

Jonathan Joel Mentor is the CEO of Successment and architect of the Digital Nomad Summit™, scaling startups and challenging institutions to evolve. UN World Summit Award Nominee  & ADOEXPO National Excellence in Exportation Award Winner  www.jonathanjmentor.co | digitalnomadsummit.co